Contributing Member of the Healthcare Councils

Names and details of certain GLG News authors are available only to GLG Clients and Council Members. GLG News authors are subject-matter experts within the GLG Councils and are available for expert consulting - by phone, in-person, or written analysis. To find out how to become a GLG client or Council Member, click here.

GLG News by this Author

Analyses are solely the work of the authors and have not been edited or endorsed by GLG.

GLG News is now G+ Insights

G+ is a community for professionals, academics and entrepreneurs to connect through online discussions and in-person meetings. You will continue to see G+ Insights (formerly GLG News) here as well as on the G+ website, where you can share and discuss the G+ Insights you read.

Pitfalls of prophylactic HIV drug usage.

August 8, 2008

Analysis of:Researchers Look to Pill, Taken Daily, to Avert H.I.V. | www.nytimes.com

The use of prophylactic drugs for HIV while nominally appealing is fraught with potential dangers that require in-depth research. With mul-tiple strains of the virus is there any drug that can give complete protec- tion? Will the impression of protection stimulate reckless behavior that could result in additional active cases? What is the benefit of such drug use if safe-sex procedures can be equally effective? All the available drugs are prohibitively expensive and medicating the entire U.S. sexual- ly active population is a guaranteed budget buster (I personally prefer the protection of missiles and tanks.) Further, other chronic diseases such as cancer and heart disease which are more prevalent do not get nearly the funding of HIV/AIDS and additional drug use with skew the situation to a greater degree. Research has recently shown that consuming HIV treatment drugs over long periods has a detrimental effect on other body systems, causing their breakdown.

Page : 11 to 1 of 1

Subscribe to Updates

By RSS